Sherwin-Williams
SHW stock analysis · Materials · Specialty Chemicals
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗Derived operating income
Derived consolidated operating income from the reviewed income statement, rather than a separately tagged subtotal. Retains other general operating income and asset impairments. Removes only separately presented interest expense, investment/interest income and other nonoperating expense. Applies only to the two recorded fiscal periods; source history can contain later restatements. Read the financial statement ↗
DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -51.8% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
18 sector peers · median 28.5×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 32.5× · -9.0% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · parent-equity fallback (scope limitation)
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Annual basis · read assumptions below
How this is calculated ↗Accrual quality
Parent-earnings fallback versus consolidated cash flow · scope limitation
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $208.28 | $227.25 | $247.65 |
| 10.0% | $152.62 | $166.05 | $180.47 |
| 12.0% | $120.41 | $130.65 | $141.64 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 23.6B | 2.6B | 3.5B | 797.6M | 25.9B |
| 2024-12-31 | 23.1B | 2.7B | 3.2B | 1.1B | 23.6B |
| 2023-12-31 | 23.1B | 2.4B | 3.5B | 888.4M | 23B |
| 2022-12-31 | 22.1B | 2B | 1.9B | 644.5M | 22.6B |
| 2021-12-31 | 19.9B | 1.9B | 2.2B | 372M | 20.7B |
| 2020-12-31 | 18.4B | 2B | 3.4B | 303.8M | 20.4B |
| 2019-12-31 | 17.9B | 1.5B | 2.3B | 328.9M | 20.5B |
| 2018-12-31 | 17.5B | 1.1B | 1.9B | 251M | 19.1B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 23.6B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-19 |
| netIncome | 2.6B | NetIncomeLoss Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2026-02-19 |
| Parent/common earnings proxy | 2.6B | NetIncomeLoss | 2026-02-19 |
| cfo | 3.5B | NetCashProvidedByUsedInOperatingActivities | 2026-02-19 |
| capex | 797.6M | PaymentsToAcquireProductiveAssets | 2026-02-19 |
| operatingIncome | 3.8B | Reviewed manual correction Derived consolidated operating income from the reviewed income statement, rather than a separately tagged subtotal. Retains other general operating income and asset impairments. Removes only separately presented interest expense, investment/interest income and other nonoperating expense. Applies only to the two recorded fiscal periods; source history can contain later restatements. | 2026-02-19 |
| assets | 25.9B | Assets | 2026-02-19 |
| equity | 4.6B | StockholdersEquity Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2026-02-19 |
| Parent book equity proxy | 4.6B | StockholdersEquity | 2026-02-19 |
| debt | 9.7B | LongTermDebt | 2026-02-19 |
| shortDebt | 1.2B | ShortTermBorrowings | 2026-02-19 |
| cash | 207.2M | CashAndCashEquivalentsAtCarryingValue | 2026-02-19 |
| shares | 250.4M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-19 |
| dividends | 789.8M | PaymentsOfDividends | 2026-02-19 |
| buybacks | 1.7B | PaymentsForRepurchaseOfEquity | 2026-02-19 |
| issuance | 140.6M | Reviewed manual correction Bounded FY2025-12-31 consolidated financing-statement extraction. Proceeds from stock options exercised: 140600000 USD [us-gaap:ProceedsFromStockOptionsExercised]. All 9 financing lines reconcile exactly to reported financing cash flow -1378600000 USD. Cash inflows from common shares, employee plans and option exercises are summed once as displayed on the statement; noncash compensation, withholding payments, preferred and noncontrolling interests are excluded. This review applies only to this issuer and fiscal period. Source limitation: the statement also aggregates other financing cash flows (net -86800000 USD). Their common-equity portion is not separately disclosed here. Issuance is the sum of separately reported common cash-issuance lines, not an independently verified gross total; additional equity flows may be inside those aggregates. | 2026-02-19 |